Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Drug major Cipla, led by MD and CEO Umang Vohra, is entering India's weight management segment and strengthening its CNS ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

He also said 'stress can increase the drive to eat', so meditating and going for a short walk might be a good alternative to snacking. For those wanting to explore weight loss medication, he added ...